Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Koami
Ikuro Koami, Tokyo JP
| Patent application number | Description | Published |
|---|---|---|
| 20090247261 | Slot Machine - A slot machine according to the present invention includes: a display device having a symbol display region for displaying a plural types of symbols; a casing; a side wall making up part of the casing, formed with an opening in a predetermined shape; a light emitting device provided inside the casing, at a position corresponding to the opening formed in the side wall; a memory for storing a plurality of light emission patterns of the light emitting device; and a controller for controlling the display device, the light emitting device, and the memory. The controller rearranges the plural types of symbols in the symbol display region during the basic game; award a payout in accordance with a predetermined combination, in the case where symbols displayed on the symbol display region are arranged in the predetermined combination; and reads the light emission patterns stored in the memory, and control the light emitting device to emit light in accordance with the read light emission pattern. | 10-01-2009 |
Takeshi Koami, Toshima-Ku JP
| Patent application number | Description | Published |
|---|---|---|
| 20100216787 | THIAZOLE DERIVATIVE - A thiazolylimidazole derivative represented by the formula | 08-26-2010 |
Takeshi Koami, Tokyo JP
| Patent application number | Description | Published |
|---|---|---|
| 20080318923 | 1,3-Dihydro-2H-Indole-2-One Compound and Pyrrolidine-2-One Compound Fused With Aromatic Heterocycle - It is intended to provide a drug which is efficacious against pathological conditions relating to arginine-vasopressin V1b receptor. More particularly speaking, it is intended to provide a drug which has a therapeutic or preventive effect on depression, anxiety, Alzheimer's disease, Parkinson's disease, Huntington's chorea, eating disorders, hypertension, digestive diseases, drug addiction, epilepsy, brain infarction, brain ischemia, brain edema, head injury, inflammation, immune diseases, alopecia and so on. As the results of intensive studies, a novel 1,3-dihydro-2H-indol-2-one compound and a pyrrolidin-2-one compound fused with a heteroaromatic ring, which are highly selective antagonists of arginine-vasopressin V1b receptor, have high metabolic stabilities and show favorable brain penetration and high plasma concentrations, are found, thereby achieving the above objective. | 12-25-2008 |
| 20090182144 | BINDING INHIBITOR OF SPHINGOSINE-1-PHOSPHATE - The present invention aims to provide compounds which have an inhibitory effect on the binding between S1P and its receptor Edg-1(S1P | 07-16-2009 |